Clinical Trial Update: Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial update involving pembrolizumab with carboplatin/paclitaxel in metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Wilson Miller | Conditions: Metastatic Malignant Melanoma | Phase 2 | Status: UNKNOWN